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This review provides a summary statement of recommended
implementations of arterial spin labeling (ASL) for clinical
applications. It is a consensus of the ISMRM Perfusion Study
Group and the European ASL in Dementia consortium, both
of whom met to reach this consensus in October 2012 in
Amsterdam. Although ASL continues to undergo rapid techni-
cal development, we believe that current ASL methods are
robust and ready to provide useful clinical information, and
that a consensus statement on recommended implementa-
tions will help the clinical community to adopt a standardized
approach. In this review, we describe the major considera-
tions and trade-offs in implementing an ASL protocol and
provide specific recommendations for a standard approach.
Our conclusion is that as an optimal default implementation,
we recommend pseudo-continuous labeling, background
suppression, a segmented three-dimensional readout without
vascular crushing gradients, and calculation and presentation
of both label/control difference images and cerebral blood
flow in absolute units using a simplified model. Magn
Reson Med 73:102–116, 2015. VC 2014 Wiley Periodicals,
Inc.
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INTRODUCTION
Arterial spin-labeled (ASL) perfusion MRI permits non-
invasive quantification of blood flow, which is an
important physiological parameter. Disorders of perfu-
sion such as stroke account for much of medical morbid-
ity in industrialized nations, and blood flow alterations
also commonly accompany other pathophysiological
changes such as cancer, epilepsy, and neurodegenerative
diseases. Through a number of methodological advances,
ASL MRI has evolved from initial single slice feasibility
studies using lengthy acquisitions to the current state-of-
the-art whereby high-quality whole brain perfusion
images can be obtained in a few minutes of scanning.
ASL MRI has been validated extensively against other
methods that use exogenous contrast agents, such as
15O-PET (1,2), and ASL implementations are now com-
mercially available on all major MRI platforms, with
demonstrated reproducibility in multicenter studies
(3,4). Clinical applications of ASL perfusion MRI in the
brain have recently been reviewed (5,6), and applica-
tions of ASL MRI outside the brain are now under
development.
The goal of this review is to provide current recom-
mendations for the implementation of ASL perfusion
MRI for clinical applications. Since the inception of ASL
more than 20 years ago (7), the quality of ASL-derived
perfusion maps has reached a level that makes the
method useful for many clinical and research applica-
tions (Fig. 1). However, 20þ years of technical develop-
ment has left potential users with a plethora of labeling
schemes, readout options, and models to quantify
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perfusion, or cerebral blood flow (CBF) in the brain,
making it difficult for a clinician or new researcher to
decide what method is most appropriate for each appli-
cation. We believe that this overabundance of choices is
an impediment to the acceptance of ASL by the clinical
community, complicating the implementation of ASL in
standard clinical care, comparisons between sites, and
the establishment of meaningful clinical trials. Further-
more, it is likely that this wide diversity of techniques
has slowed implementation and adoption of ASL by MRI
vendors, thereby limiting its availability.
In 2011–2012, the Perfusion Study Group of the Inter-
national Society for Magnetic Resonance in Medicine
(ISMRM) and the European consortium ASL in Dementia
(AID) (funded through a grant from the European Union
COST agency as COST Action BM1103) both recognized
that a clear set of recommendations was needed in order
to encourage the adoption and improve the utility of
ASL, and resolved to collaborate on a consensus state-
ment of current recommendations (the present review).
In October 2012, an ISMRM workshop on perfusion
imaging and an AID Action Workshop were held on con-
secutive days in Amsterdam, with a primary focus on
open and inclusive discussion of current recommenda-
tions for implementation of ASL for clinical applica-
tions. A draft of this document was further discussed at
a Virtual Meeting of the ISMRM Perfusion Study Group
in August 2013. This document reports on the consensus
that was reached during those meetings. It is cosigned by
the participants, as well as additional members of the
ISMRM Perfusion Study Group and the COST-sponsored
AID Consortium, and is further endorsed by the American
Society of Neuroradiology and the American Society of
Functional Neuroradiology. A complete list of endorse-
ments is available in the Supporting Information online.
Although ASL MRI can be used to study any organ,
this recommendation focuses exclusively on ASL in the
brain, which to date is the most common and well-
studied application. Recommendations will be discussed
in seven sections covering the main aspects of ASL: 1)
hardware considerations; 2) ASL approaches; 3) time
delay between labeling and imaging; 4) background sup-
pression; 5) readout approaches; 6) postprocessing meth-
ods; and 7) ASL in the clinical setting.
ASL is still a rapidly developing field, both in terms of
technical innovation and applications. In no way is this
review intended to suggest that there is only one or a
few correct ways to perform ASL, nor should it have the
effect of slowing innovation or development of the field.
Rather, it is intended to document the current recom-
mendations for the optimal use of ASL in clinical appli-
cations in order to encourage implementation of robust
ASL methods and promote uniformity of data across
scanner types, sites, and studies. We expect that as ASL
methods continue to develop, these recommendations
should be updated, and recommend that this consensus
FIG. 1. Example of whole brain ASL imaging of cerebral blood flow at 3T using the recommended parameters in a normal subject, high-
lighting the typical image quality and expected contrast between gray and white matter.
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statement be revised on a regular basis, perhaps every
3–5 years.
A BRIEF OVERVIEW OF ASL
ASL (7,8) uses arterial blood water as an endogenous dif-
fusible tracer by inverting the magnetization of the blood
using radiofrequency (RF) pulses. After a delay to allow
for labeled blood to flow into the brain tissue, labeled
images are acquired that contain signal from both labeled
water and static tissue water (9). Separate control images
are also acquired without prior labeling of arterial spins,
and the signal difference between control and labeled
images provides a measure of labeled blood from arteries
delivered to the tissue by perfusion. The lifetime of the
tracer is governed by the longitudinal relaxation time of
blood, which is in the range of 1300–1750 ms at clinical
field strengths (10,11). Many implementation choices of
ASL are influenced by the fact that this lifetime is simi-
lar to the transport time from the labeling position to the
tissue (known as the arterial transit time [ATT]). The
fundamental trade-off is that a short delay does not allow
for complete delivery of the labeled blood water to the
tissue, whereas a long delay results in strong T1 decay
and therefore reduced signal-to-noise ratio (SNR). The
ATT varies between individuals, regionally, and between
healthy and pathological tissue (4,12).
Hardware Considerations
A field strength of 3T is recommended when available,
though satisfactory results can be obtained at 1.5T. The
advantage of increased field strength is higher SNR,
which results from a combination of higher intrinsic
SNR and longer T1 (13). The lower SNR at 1.5T can be
compensated for by a combination of decreased spatial
resolution and/or increased scan time. The recom-
mended parameters given below are valid for both 3T
and 1.5T.
The use of multichannel receive head coils with eight
or more channels is advised for ASL. Multichannel head
coils not only increase the SNR of the MRI images, but
also enable the use of parallel imaging acceleration
(14,15), which can be exploited to decrease the echo
time and the total readout duration (16). Without the use
of multichannel head coils, the user is advised to lower
the spatial resolution to compensate for the lower SNR.
Because ASL is a subtractive technique it is sensitive
to motion, and segmented three-dimensional (3D) acqui-
sition methods (see the “Readout Approaches” section
later in this review) incur additional motion sensitivity.
Therefore, patient motion should be minimized as much
as possible. Motion sensitivity can also be partially miti-
gated by the use of background suppression, which pro-
vides strong motivation for the use of that feature (see
the “Background Suppression” section later in this
review).
ASL Labeling Approaches
ASL labeling approaches can be grouped into three
types: continuous labeling (7,8,17), pulsed labeling (18–
20), and velocity selective labeling (21). Velocity selec-
tive ASL is currently considered to be in development
and requires additional validation for routine clinical
care; therefore, only continuous and pulsed labeling are
discussed here.
Pulsed and continuous ASL labeling methods differ
fundamentally in both the spatial extent and the dura-
tion of the labeling (Figs. 2 and 3), and these differences
give rise to the strengths and weaknesses of each
approach. In the continuous ASL, labeling occurs over a
long period, typically 1–3 s, as blood flows through a
single labeling plane and is inverted by an effective con-
tinuous RF energy. This process is known as flow-driven
adiabatic inversion. There are two distinct forms of con-
tinuous ASL: 1) continuous ASL (CASL), in which one
single, long label is applied (8), and 2) pseudo-
continuous ASL (PCASL), in which 1000 or more shaped
RF pulses are applied at a rate of approximately one per
millisecond (17). CASL was originally implemented for
human use as a single slice technique (22) but was later
extended to multislice imaging (23). Both forms of CASL
constitute long label scenarios, but PCASL provides
superior labeling efficiency and is compatible with mod-
ern body coil RF transmission hardware that is now
ubiquitous on clinical MRI scanners. Accordingly,
PCASL is the continuous ASL labeling scheme that is
recommended for clinical imaging and is thus referred to
henceforth when discussing CASL. In contrast, pulsed
FIG. 2. Schematic diagram of imaging and labeling regions for
CASL/PCASL and PASL. In CASL/PCASL, labeling occurs as
blood flow through a single labeling plane, while in PASL, a slab
of tissue, including arterial blood, is labeled.
FIG. 3. Timing diagram for CASL/PCASL and PASL. For QUIPSS II
PASL, TI1 is the bolus duration, and is analogous to the labeling
duration in CASL/PCASL. The PLD in CASL/PCASL is analogous
to the quantity (TI-TI1) in QUIPSS II PASL.
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ASL (PASL) uses a single short pulse or a limited num-
ber of pulses, with a total duration of typically 10–20
ms, to invert a thick slab of arterial water spins
(20,24,25). The SNR of the PCASL approach is higher
than that of PASL for two reasons. First, the temporal
duration of the labeled bolus is longer in PCASL, and
this is proportional to the volume of labeled blood that
is delivered to the tissue, translating to an increase in
SNR. In PASL, the bolus is derived from a labeling slab
that is 10–20 cm thick, which is limited by the spatial
coverage of the transmit RF coil. The arteries supplying
blood to the brain have mean velocities of 20 cm/s, so
the temporal duration of the generated PASL bolus is
typically 1 s or less. This smaller bolus translates to a
shorter labeling duration and consequently lower SNR in
PASL compared with CASL. Second, even for a bolus of
equal temporal duration, and correction for lower label-
ing efficiency, the labeled magnetization delivered using
PCASL is higher than that of PASL. For both methods, a
spatial gap exists between the labeling and imaging
regions. The labeling plane for CASL is typically in
approximately the same location as the distal end of the
labeling slab in PASL (Fig. 2). For PASL, a single pulse
simultaneously inverts the entire labeled bolus, and this
bolus decays with time constant T1 for the entire time
between the inversion pulse and image acquisition. For
CASL, blood is inverted as it passes through the labeling
plane, and therefore the bolus is, on average, inverted
later in time than in PASL, leading to less T1 decay, and
a larger ASL signal (19).
Ease of use and adequate SNR are two critical consid-
erations in the implementation of robust clinical perfu-
sion imaging using ASL. We therefore recommend
PCASL as the workhorse labeling approach with ASL
images collected at a single postlabeling delay (PLD). As
clinicians gain and share experience, it will be possible
to adjust the ASL acquisition to account for issues that
arise in cerebrovascular and/or neurological studies,
such as prolonged or heterogeneous blood transit times.
In these cases, multiple (PLD) values can be used in
either PCASL or PASL approaches, since the hemody-
namic information made available by quantifying ATT
delays can improve quantification of CBF, or serve as
useful hemodynamic measures in and of themselves
(12,26)
Implementation details of both CASL and PASL label-
ing methods are described below.
CASL/PCASL Approaches
In CASL, a constant gradient is applied over the labeling
period, and a constant RF pulse, tuned to resonate at the
labeling plane, produces the flow-driven inversion as
described above. In PCASL, the currently preferred
implementation of CASL (17), the continuous RF is
replaced by a long train of slice-selective RF pulses
applied at the labeling plane, along with a train of gradi-
ent pulses that have a small but non-zero mean value.
The mean value of both RF and gradient pulses over
time are similar to those used in CASL, and the mecha-
nism of inversion is the same. PCASL is preferred over
CASL for two reasons. First, CASL produces significant
saturation of brain tissue through magnetization transfer
effects, leading to subtraction errors between label and
control states. In addition, pulse sequence modifications
that have been introduced to reduce these errors lead to
decreased labeling efficiency. In PCASL, larger gradients
are present during RF pulses, increasing the resonant off-
set of the pulses relative to brain tissue, and thereby
decreasing magnetization transfer effects and increasing
labeling efficiency. Second, CASL requires continuous
application of RF power, which most current RF ampli-
fiers cannot provide without modification, whereas
PCASL is compatible with existing RF amplifiers.
Several variants of PCASL have been proposed, and
whereas some variants can correct for potential artifacts
and others can provide more information such as vascu-
lar territories, we currently recommend use of the basic
implementation described here for robustness and sim-
plicity and because there is sufficient experience in clin-
ical use to support this recommendation.
The RF pulse spacing should be as short as possible.
This directly affects the sensitivity of the labeling pro-
cess to resonance offsets at the labeling plane, as well as
labeling efficiency (27–29). A spacing of 1 ms from the
center of one pulse to the center of the next is a good
goal, but additional insensitivity to frequency offsets is
gained with further reduction of the pulse spacing. For
the labeling pulse, the slice-selective gradients should be
10 mT/m with a mean gradient of 1 mT/m, and the
RF pulses should have a mean B1 of 1.5mT (17,27). The
slice profile of the RF pulses should be sufficiently nar-
row to avoid labeling at the aliased labeling planes gen-
erated by the periodic pulses [see Dai et al. (17)]. In
order for the pulses to remain in phase with the spins,
the phase fn of the nth RF pulse should be fn ¼ gnGTZ,
where g is the gyromagnetic ratio, Gis the mean gradient,
T is the RF pulse spacing, and Z is the distance from the
isocenter of the gradients to the labeling plane (17). For
the control condition, the phase of every other RF pulse
should be shifted by p relative to the label condition,
and the refocusing gradient lobes increased in amplitude
such that the mean gradient is zero. In the literature, this
gradient condition is referred to as an unbalanced con-
trol because the gradients in the label and control condi-
tions are different (unbalanced). A balanced control is
used in some implementations to facilitate vascular terri-
tory imaging, but has greater sensitivity to off-resonance
effects, and is not preferred for basic PCASL (27).
The optimal label duration is determined by the relax-
ation time of the label (T1), and also by the effect of the
label duration on the repetition time (TR). The ASL sig-
nal increases with label duration, but with diminishing
returns for label durations much longer than the T1 of
blood. Longer durations increase TR, and thereby
decrease the number of averages obtained per unit time.
Durations as long as 4 s may increase SNR and help pre-
serve signal when ATT is unexpectedly long. However,
long labeling durations increase signal dependence on
tissue T1 and may be unattainable due to power deposi-
tion and background suppression constraints. Because
clinical experience with longer labeling times is less
extensive, we recommend 1800 ms labeling duration in
Table 1 as a current compromise between SNR increase
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and disadvantages of greater power deposition, T1 sensi-
tivity, and limited clinical experience. (9,30).
Several methods have been used to choose the location
of the labeling plane. In the ideal case, the labeling plane
should be located in a region where the relevant feeding
arteries are relatively straight and perpendicular to the
labeling plane. This can be accomplished using an angio-
gram if one is available, and a fast angiogram that is suf-
ficient for this purpose can be obtained in less than 1
min. However, the use of an angiogram for this purpose
can add overall scan time and provides more opportuni-
ties for operator-related variability. A viable alternative
is to use anatomical landmarks for selection of the label-
ing plane, and at least two approaches have been used
successfully. One approach involves choosing a plane
that is 85 mm inferior to the anterior commissure-poste-
rior commissure (AC-PC) line (31). This method is appro-
priate for adults but is likely suboptimal for children. A
second choice is to place the labeling plane just below
the inferior border of the cerebellum to ensure labeling
of the posterior cerebral circulation (32). It would be
helpful if future ASL implementations allowed the user
to easily control the location of the labeling plane for
PCASL, perhaps through the graphical prescription inter-
face of the scanner. There is not yet strong evidence that
one of these methods is clearly superior to the other, and
choosing an approach that integrates well with the local
workflow is reasonable. Likewise, the choice of
angiogram-based versus anatomical selection of the label-
ing plane should depend on the time constraints of the
application and the consistency and expertise of the
scanner operators.
When the RF pulses are not on-resonance at the label-
ing plane, inefficient labeling can result. It is therefore
useful to avoid labeling in regions of strong susceptibil-
ity artifacts, such as air–bone interfaces. However, such
failures are rare and are considered relatively easy to rec-
ognize with some experience, as they typically affect a
single vascular territory and result in uniformly low sig-
nal throughout the territory, with no apparent compensa-
tory redistribution of flow (Fig. 4). More subtle
reductions in labeling efficiency may also occur due to
alterations in B0 or B1 at the labeling location. There are
currently several methods under investigation to charac-
terize, prevent, or correct this artifact, including methods
to shim or measure the fields at the labeling plane and
correct for field offsets in the labeling process
(28,29,33,34). However, these methods add complexity to
the scanning process and have not yet been streamlined
and tested for robustness in the clinical setting, and are
therefore not recommended for general use at this time.
Because gross labeling artifacts are relatively rare and
can be recognized with experience, this potential prob-
lem is outweighed by the benefits of PCASL described
above, and PCASL remains our clear recommendation as
a first choice for ASL.
Pulsed ASL Approaches
In PASL, an RF pulse inverts a slab of tissue, including
arteries, proximal to the area of interest. Many PASL
labeling methods, and associated acronyms, have been
introduced to produce this inversion, but overall, the
methods are more similar than different. In publications
we recommend identifying the ASL method first as
PASL, and secondarily with the variant name in order to
reduce confusion about the apparent wide variety of
ASL methods. One difference that can be observed
between PASL methods is in the labeling of spins that
flow into the region of interest from the distal side.
When whole brain coverage is specified, then the region
distal to the imaging region is outside the head, and this
distinction becomes irrelevant. For smaller imaging
slabs, vessels entering from above the slab (mostly veins)
may produce ASL signals. For flow-sensitive alternating
inversion recovery (FAIR) (20) and its variants, inflow
from above will produce a positive ASL signal. For echo
planar imaging and signal targeting with alternating RF
(EPISTAR) (13), inflow from above will produce a nega-
tive signal, and for proximal inversion with a control for
off-resonance effects (PICORE) (25), pulsed star labeling
of arterial regions (PULSAR) (35) and double inversions
with proximal labeling of both tag and control images
(DIPLOMA) (36), inflow from above produces no ASL
signal. These labeling methods are all acceptable, but the
user should be aware of the potential differences in the
signal from inflowing distal spins. For efficient inver-
sion, RF pulses should be insensitive to B1 inhomogene-
ities, and the use of adiabatic inversion pulses (37,38) is
therefore advocated. The total RF power during the label
and control conditions should be equal to minimize mag-
netization transfer effects (39), a condition which is met
by most implementations of PASL, including those refer-
enced above. In addition, the slice profile of the slab-
selective inversion pulse should be optimized to avoid
overlap with the imaging volume (37,38). Saturation of
the imaging volume just before and/or after the label and
control pulses is recommended to minimize any residual
label/control differences from magnetization transfer
and/or slice profile effects, and also as an initial step in
the background suppression process described below.
The labeling inversion pulse should have been tested in
a phantom, showing an inversion efficiency greater
than 95%.
As mentioned above, a drawback of PASL is that it
creates a bolus of labeled spins with an unknown and
relatively short temporal width. It is possible to control
Table 1
Recommended Labeling Parameters
Parameter Value
PCASL labeling duration 1800 ms
PCASL PLD: neonates 2000 ms
PCASL PLD: children 1500 ms
PCASL PLD: healthy subjects <70 y 1800 ms
PCASL PLD: healthy subjects >70 y 2000 ms
PCASL PLD: adult clinical patients 2000 ms
PCASL: average labeling gradient 1 mT/m
PCASL: slice-selective labeling gradient 10 mT/m
PCASL: average B1 1.5 mT
PASL TI1 800 ms
PASL TI Use PCASL PLD
(from above)
PASL labeling slab thickness 15–20 cm
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the width of the labeling bolus by means of the QUIPSS-II
modification (40), in which a slab-selective saturation
pulse that matches the labeling slab is used to remove the
tail end of the labeled bolus. This adaptation is necessary
for quantification of CBF using PASL with a single delay
time. However, for single delay time measurements
PCASL is, in general, the preferred labeling method, as
both SNR and repeatability are higher (41).
The labeling slab should have a thickness between 15
and 20 cm, with a gap to the imaging volume that is
minimized subject to the constraint that the labeling
pulse does not significantly perturb the magnetization in
the imaging volume (typically a gap of 1–2 cm). For the
purpose of generating a labeled bolus (and therefore an
ASL signal) of maximum size, the thickness of the label-
ing slab should be as large as possible. However, three
factors limit the optimal size of the labeling slab. First,
for all PASL labeling methods other than FAIR, the
width of the transition zone between inverted and unin-
verted blood at the edge of the labeled bolus is propor-
tional to the thickness of the labeling slab (for FAIR, it is
proportional to the thickness of the imaging slab). For
large slab thickness, the transition zone becomes larger,
requiring a larger gap between labeling and imaging
slabs, which in turn increases arterial transit times and
longer transit delays. Second, the RF transmit coil is lim-
ited in size, and the transmit B1 falls off with distance
from isocenter. For optimal quantitation of CBF, the
labeled bolus should consist of completely inverted
blood, and so the labeling slab should be limited to the
region of relative homogeneity of the transmit RF fields.
Finally, if the labeling bolus is beyond the homogeneous
region of the transmit RF coil, not only will the tail end
of the labeled bolus be incompletely inverted, but this
partially inverted blood will take a long time to clear
from the labeling slab, requiring a longer TR before the
next labeling pulse and thus lowering time efficiency.
Empirically, 15–20 cm has been found to be a good com-
promise between these factors.
One potential advantage of PASL over PCASL is lower
RF power deposition, and this should be considered
when the specific absorption rate is limiting. Up to 3T,
specific absorption rate in PCASL has not been found to
be a limiting factor across the range of patient sizes from
infants (42) to adults (17).
Time Delay Between Labeling and Imaging
As noted in the Introduction, ASL methods employ a
time delay between the application of the labeling pulse
and image acquisition in order to allow for the labeled
bolus to flow into the target tissue in the imaging region
(Fig. 3). This time delay is used to allow labeled arterial
water to reach the microcirculation and reduce the con-
tribution of arterial signals to the perfusion image, which
would otherwise appear as spots of apparent hyperperfu-
sion. The delay also reduces the sensitivity of perfusion
quantification to variations in transit time (9). The termi-
nology that has developed to describe this delay is differ-
ent for PCASL and PASL, which can be confusing, and
is defined here. For PCASL, two time points define the
timing of the labeling pulse train, the beginning, and the
end, which are separated by the labeling duration of
1500–2000 ms (see above). The time between the end of
this pulse train and image acquisition is referred to as
the PLD. For PASL, the timing of the labeling pulse is
characterized by a single time point, since the labeling
pulse is nearly instantaneous (tens of milliseconds). The
time from the application of this pulse to image acquisi-
tion is referred to as the inversion time (TI). Because
PLD refers to the time at which the end of the labeled
bolus leaves the labeling plane in PCASL, the analogous
time in PASL is the time at which the end of the labeled
bolus passes through the distal end of the labeling slab.
In PASL, this time is generally unknown, as the tempo-
ral width of the labeled bolus in PASL is not controlled.
With the QUIPSS II modification mentioned earlier, the
bolus width is controlled and is referred to as TI1. The
PLD in PCASL is analogous to the quantity (TI-TI1), as
indicated in Fig. 3.
Single PLD/TI Methods
For CBF quantification using PCASL, the ideal case is that
the PLD is set just longer than the longest value of ATT
present in the subject. Under these conditions, the entire
labeled bolus is delivered to the tissue prior to image
acquisition, and the CBF measurement will be unbiased
by incomplete delivery. However, because the ASL signal
decays with time constant T1 after labeling, it is too costly
in terms of SNR to be extremely conservative in the choice
of PLD such that PLD is guaranteed to be strictly longer
than ATT under all circumstances. In healthy gray matter,
ATT can vary between 500–1500 ms depending on the
labeling location and the tissue location in the brain, but
in cerebrovascular disease and in deep white matter, ATT
can be 2000 ms or longer. The choice of PLD is therefore a
compromise, such that SNR is acceptable, and that in the
large majority of cases the ASL signal will accurately
reflect CBF. However, it should be understood that areas
of low ASL signal may reflect some combination of low
CBF and unusually long ATT, and not specifically low
CBF. In many cases, long ATT can be identified by the
presence of intraluminal signal in the same vascular distri-
bution due to spin label remaining in arteries. The range
of expected ATT depends on age, and the PLD should be
adjusted accordingly. Recommended values for PLD are
given in Table 1, with a PLD of 2000 ms recommended for
the clinical adult population, independent of age, given
the potential for a wide variety of pathologies, which are
often not known in advance of imaging.
Using PCASL with a single value of PLD, as described
above, is a robust and straightforward means of obtaining
reliable CBF images, and is therefore recommended as a
standard clinical protocol. PASL with the QUIPSS II
modification is analogous to PCASL in that it has a well
defined labeled bolus duration, and allows for quantifi-
cation of CBF using a single value of TI (40). However,
this approach is only recommended when PCASL is
unavailable, as the SNR of PASL is significantly lower.
For PASL with QUIPSS II, TI1 should be set to 800ms,
and the TI set as shown in Table 1. Note that the recom-
mended values of PLD for PCASL are the same as the TI
for PASL. This effectively results in a PLD for PASL that
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is 800 ms shorter than that for PCASL. While this not
ideal in that it increases the likelihood of incomplete
delivery of labeled blood to the imaging region in PASL,
it also increases SNR and was felt to be a necessary
trade-off to compensate for the lower SNR inherent to
PASL. Alternative approaches to recovering SNR, such
as decreased spatial resolution, are also potentially effec-
tive, but have not been thoroughly tested in clinical
practice.
Multiple PLD/TI Methods
The methods described above for single PLD/TI ASL
imaging provide rapid and robust measures of CBF that
are relatively insensitive to ATT. However, they do not
provide measures of ATT, nor do they provide direct evi-
dence that an abnormally long ATT may be introducing
errors into the CBF measurement. Such effects might be
particularly important in patients with steno-occlusive
diseases. These effects have long been studied using
PASL with multiple values of TI and fitting the data to
estimate both CBF and ATT (43–46) but can also be stud-
ied with CASL or PCASL by varying PLD and labeling
duration (30,32,47) or with more complex but efficient
Hadamard time encoding strategies (48–50). While these
multi-TI/PLD methods provide additional information,
they are more complex, require more measurements and
processing, and are therefore not recommended as a
default ASL method at the present time. However, for
those interested in the estimation of ATT or the most
precise quantitation of CBF, we encourage the use of
multi-TI/PLD methods. The ATT values estimated using
this approach may themselves be of diagnostic utility,
and the collection of ATT data on clinical populations
will allow for more reliable optimization of PLD for sin-
gle PLD imaging in the future, or may point to popula-
tions in which multi-TI/PLD imaging is especially
useful.
Background Suppression
In gray matter, perfusion replaces 1% of the brain
water with in-flowing blood water every second. There-
fore, a 2-s bolus of labeled blood in an ASL measurement
can only perturb 2% of the magnetization in a typical
brain voxel. Considering the PLD and T1 relaxation, the
difference between label and control images is typically
<1% of the relaxed brain signal. Unfortunately, subject
motion, which is typically the dominant noise source in
ASL, produces signal fluctuations (noise and/or artifacts)
that are proportional to the signal intensity in the unsub-
tracted images. Therefore, if it is possible to decrease the
signal intensity of the unsubtracted images without a
proportional decrease in the ASL difference signal, the
overall SNR of the ASL measurement can be improved
substantially (51,52). Such a decrease of the signal inten-
sity unmodulated by labeling can be accomplished using
a combination of spatially selective saturation and inver-
sion pulses. This technique is usually referred to as
background suppression (BS). ASL MRI scans incorporat-
ing background suppression have markedly improved
temporal SNR, which is of particular value in clinical
ASL where scan times must be as short as possible and
inferences are being made on perfusion data from a sin-
gle scan (53,54).
Details about the implementation and optimization of
BS for ASL can be found in (17,55,56), but briefly: an
initial saturation pulse selective to the imaging region,
FIG. 4. a: Example of poor PCASL labeling within the right anterior circulation due to poor labeling of the right internal carotid artery.
Note the loss of ASL signal confined to this territory without compensatory collateral flow. b, c: In this case, confirmation was obtained
with a (b) normal dynamic susceptibility contrast CBF map and (c) normal MR angiogram of the circle of Willis. d: CT angiogram demon-
strates surgical clips in the region of the right internal carotid artery (arrows), which may have been responsible for the poor labeling
due to susceptibility effects.
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followed by carefully timed inversion pulses, results in
the longitudinal magnetization of static tissue passing
near or through zero at the time of image acquisition.
The blood that is to be labeled by the labeling pulses
does not experience the initial saturation, but does expe-
rience the inversion pulses. For perfect inversion pulses,
each inversion changes the sign of the ASL label/control
magnetization difference, but nominally does not affect
the magnitude of this difference. Thus, the ASL signal is
preserved, while the static tissue signal is nearly
eliminated.
Two important features of BS should be emphasized.
First, there is a trade-off in the number of inversion
pulses used for BS. The larger the number of inversion
pulses, the more accurately static tissue can be sup-
pressed over a wide range of tissue T1 values. The trade-
off is that each inversion pulse reduces the ASL label/
control difference signal. The efficiency of the inversion
pulses is high but not perfect, and is typically 95%, so
each inversion pulse reduces the ASL signal by 5%. In
each implementation, this trade-off should be evaluated,
and the efficiency of the inversion pulse measured in
vivo or appropriate phantoms (56), so that this source of
signal loss can be accounted for in the calculation of
CBF. Generally, two pulses can be considered a good
trade-off. We do not, however, recommend efficiency
measurement on each subject, as the added time
required does not seem justified by any observations of
large intersubject differences. A second key feature is
that BS only nulls the magnetization of static tissue at
one point in time, after which the magnetization of static
tissue continues to grow toward the equilibrium state by
relaxation. For imaging methods that employ a single
excitation per TR, such as the segmented 3D approaches
describe below, BS can be highly effective, as the null
point of the magnetization can be timed to coincide with
the excitation pulse. For methods that require multiple
excitations per TR, such as multislice single-shot two-
dimensional (2D) methods, BS can be optimal for one
slice, but is progressively less efficient for other slices.
This difference in BS efficiency can interact strongly
with the choice of imaging methods for ASL, as dis-
cussed below.
Readout Approaches
For the readout module of ASL, segmented 3D sequences
are the preferred methodology because they use a single
excitation per TR, which is optimal for BS, and because
they can be made SNR efficient and relatively insensitive
to off-resonance effects. It is anticipated that single-shot
3D readout may be the preferred option in the future, but
these methods are not yet sufficiently well tested to rec-
ommend for general use at this time. Multislice single-
shot 2D echo-planar imaging (EPI) or spiral readout
should be considered a viable alternative to segmented 3D
sequences, because they are available on all systems and
are insensitive to image artifacts from motion. However,
2D imaging results in poor BS for most slices, as well as
longer scan time. Examples of ASL with 2D and 3D read-
outs are shown in Fig. 5, and more detailed comparisons
FIG. 5. 2D (a) versus 3D (b) readout ASL imaging in a normal subject. Both sets of images were acquired with 5 min of imaging at 3T
with PCASL labeling (label duration, 1.5 s; PLD, 2 s). The 2D readout method was a single-shot gradient echo spiral. The 3D readout
was a segmented stack of spirals fast spin echo. Arrows indicate the artifacts associated with the 2D single-shot method in regions of
high susceptibility. Parallel imaging approaches could be used to improve such artifacts associated with single-shot gradient echo
imaging.
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between these methods in ASL can be found in Vidorreta
et al. (57) and Nielsen and Hernandez-Garcia (58).
Segmented 3D Readout
As a default readout, 3D segmented methods such as 3D
multiecho (RARE) stack of spirals (52,57) or 3D GRASE
(59–61) are recommended. These methods provide nearly
optimal SNR for measurement of the magnetization pre-
pared by the ASL pulses, and they are relatively insensi-
tive to field inhomogeneity. They strike a balance
between the T2* insensitivity of pure RARE methods,
and the time efficiency of pure EPI or spiral acquisitions,
enjoying most of the benefits of both. Compared with 2D
multislice readouts, these methods allow for significantly
better BS. BS is only optimal at one point in time, and
because segmented 3D readouts only require one excita-
tion per TR period, the excitation can be timed to pro-
vide a very high degree of BS. BS parameters should be
optimized for minimal static tissue signal, and a complex
difference between label and control images should be
calculated to form the ASL signal, as a difference
between magnitude reconstructed images that are near
zero will generate sign ambiguities. Note that the use of
BS for segmented 3D acquisitions is critical for ASL, as
shown in Fig. 6. Segmented methods require data consis-
tency between excitations, and without BS, the motion-
related artifacts will generally dominate the ASL signal
(Fig. 6, bottom right). For 3D readouts, the time within
each TR that is allocated to image acquisition is gener-
ally shorter than that of multiple 2D slices (unless the
number of slices is very small), allowing for more effi-
cient use of time (ie, shorter TR, or longer labeling time
per TR). 3D RARE stack of spirals and 3D GRASE per-
form similarly (57), and we recommend whichever of
these two is better optimized on a particular system. We
note that the stack of spiral acquisition provides natural
oversampling at the center of k-space, which can
improve motion insensitivity, but also has the potential
for in-plane blurring due to resonance offsets. In con-
trast, GRASE typically does not oversample k-space, and
resonance offsets in 3D GRASE result in in-plane distor-
tion rather than blurring. For this multishot acquisition,
label and control conditions for a given shot should be
acquired sequentially in time (ie, the label/control modu-
lation should be the inner-most loop) to achieve the
most accurate label/control subtraction. The user should
also be aware that T2-related signal modulation across
echoes can result in through-plane blurring. If the image
reconstruction software is vendor-supplied, we recom-
mend inquiring as to what methods are used to correct
for image blurring and/or distortion so that the images
can be interpreted accordingly. The methods and param-
eters used for these corrections should be described in
manuscripts that report ASL data, as they can have a sig-
nificant impact on the comparison of data between sites.
See Table 2 for recommended imaging parameters.
Single-Shot 2D Readout
As a second choice, 2D single-shot imaging methods can
be used effectively for ASL. EPI and spiral methods have
been used extensively, while single-shot RARE and bal-
anced SSFP are also viable, but are less common and
much less thoroughly tested for ASL. EPI and spiral
have similar performance to one another for ASL, again
with small differences. Spirals allow for shorter echo
time (TE) to reduce T2/T2* weighting but suffer from
off-resonance–related blurring. EPI has longer minimum
TE but demonstrates distortion rather than blurring in
the presence of resonance offsets. As for 3D imaging, we
recommend whichever of the two methods is better opti-
mized on a particular system. Generally, an ascending
slice order is recommended for single-shot 2D readouts.
One advantage of single-shot imaging methods is that
they are immune to motion artifacts from the
Table 2
Recommended Imaging Parameters
Parameter Value
Spatial resolution 3–4 mm in-plane, 4–8 mm through-plane
3D RARE stack of spiral or 3D GRASE 4–15 ms readouts, turbo-factor of 8–12, echo train of up to 300 ms
2D EPI or spiral Single shot, minimum echo time
Scan time 4 min for acute cases, 2 min with lower spatial resolution
Field strength Use 3T when available; for 1.5T, use lower spatial resolution
Vascular crushing gradients Not recommended under most circumstances; when applicable,
use VENC ¼ 4 cm/s in the Z-direction
FIG. 6. PCASL images acquired using 2D single-shot and 3D seg-
mented spiral readouts, with and without BS.
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inconsistency between excitations that can affect multi-
shot methods. However, this sensitivity in 3D segmented
imaging is minimized by the use of efficient BS, as
shown in Fig. 6. For 2D imaging, BS will only be optimal
for one or a few slices. Although this is generally a draw-
back, the residual static tissue signal can be useful in
two ways. First, magnitude image reconstruction can be
used, which can be simpler than complex reconstruction
and coil combination; second, the residual signal can be
used for image registration prior to label-control subtrac-
tion. While the effects of BS in 2D single-shot imaging is
much less dramatic than in 3D imaging (Fig. 6), signifi-
cant decreases in signal fluctuations are seen, especially
with significant patient motion, and the use of BS is rec-
ommended. See Table 2 for further recommended imag-
ing parameters.
Parallel Acceleration
Parallel imaging can be used to reduce imaging time by
undersampling k-space and using the spatial information
from multichannel coils to reconstruct undersampled
data. This acceleration can come at a cost in SNR, and as
ASL is significantly SNR limited, parallel acceleration
should be used judiciously. We recommend the use of
moderate acceleration factors of 2–3 for the following
purposes: to reduce the echo train length for RARE-
based methods such as 3D RARE stack of spirals or 3D
GRASE, when the echo train would otherwise be signifi-
cantly longer than T2; or to reduce the echo time for 2D
gradient echo EPI (this is not necessary for 2D spiral).
Vascular Crushing Gradients
By means of the insertion of vascular crushing gradients
directly after the excitation pulse or a motion-sensitized
T2-preparation module, vascular artifacts can be reduced
by dephasing signal from label still present in larger
arteries at the time of imaging. Elimination of this signal
is based on the velocity of the spins in the direction of
the gradients (frequently only the feet–head direction).
Because of the additional gradients or the use of a T2-
preparation module, the effective TE will be prolonged
when using vascular crushing, thereby introducing T2
(or T2*) contrast into the ASL-image and a reduction in
SNR. This should be taken into account in the calcula-
tion of CBF (62).
As a default implementation, we discourage the use of
vascular crushing gradients, given that they may remove
important clinical information, such as the presence of
delayed flow and arteriovenous shunting. For single PLD
imaging, the PLD is chosen so that it will be longer than
ATT for the majority of cases. When this condition is
true, the labeled bolus will be delivered to target tissues
prior to imaging, and little if any labeled blood will be
in larger arteries at the time of imaging. In this case, the
effects of vascular crushing gradients on the ASL image
will be minimal. However, when regions exist with
ATT>PLD, bright vascular signals will appear in the
ASL image, and these signals would be removed using
vascular crushing gradients. For some applications, such
as in the setting of collateral flow (63), the presence of
bright vascular signal may be a useful indicator that
regions with long ATT are present and that quantitative
CBF values distal to these regions may be in error; this
information may itself be of diagnostic value. In arterio-
venous malformations, the identification of ASL signals
in veins may also be clinically useful (64,65) (Fig. 7).
We encourage the implementation of vascular crushing
gradients as a user-controlled option, as they will likely
be useful under some circumstances, but not others. For
applications such as in tumors, bright intravascular sig-
nals may obscure more subtle underlying perfusion-
related signals of interest, and vascular crushing gra-
dients may be desirable. When time is available, two
ASL scans with and without vascular crushing gradients
may provide the most useful information. These choices
are related to the manner in which ASL will ultimately
be used in the clinical setting, which is not yet well
established. We encourage users to become familiar with
the effects outlined above, and to experiment with this
option.
For multi-PLD/TI imaging, ATT can be estimated in
addition to CBF, as discussed above. Without vascular
crushing gradients, the measured ATT will indicate the
time at which the labeled bolus arrives in the voxel,
while with vascular crushing gradients the measures
ATT will reflect the arrival time in the microvasculature.
These different ATTs may be of interest in different
applications. Without vascular crushing gradients, care
should be taken to include in-flow effects in the model,
otherwise the calculated CBF may not be correct.
An additional note on the use of vascular crushing gra-
dients is that when perfusion imaging is performed as
part of a group analysis, vascular artifacts can complicate
the analysis due to the presence of hyperintense spots at
irregular locations (corresponding to large arteries), and
the use of vascular crushing gradients could be consid-
ered in this setting.
Vascular crushing is characterized by the VENC, or the
velocity at which flow induces a phase shift of 180.
Roughly speaking, spins are dephased above VENC, and
remain visible below VENC. Very high VENC allows
large arterial signal to remain, while very low VENC
results in prolonged ATT and low SNR. When used, we
recommend vascular crushing in the feet–head direction
with a VENC of 4 cm/s as a good trade-off.
Postprocessing Methods
In routine clinical practice, visualization of the ASL dif-
ference (label–control) images is most useful, as most
disorders of perfusion result in easily visualizable focal
changes. However, we recommend that additional CBF
imaging in quantitative units also be provided, given
that some disorders do cause global changes (such as
hypercapnia or hypoxic ischemic injury).
Quantification of CBF
One of the most attractive features of ASL is its ability to
quantify perfusion, an important indicator of tissue
health as well as neuronal activity. For quantification of
CBF from single PLD/TI ASL data, a relatively basic
model is proposed. The major assumptions of this
model are:
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1. The entire labeled bolus is delivered to the target
tissue. This is the case when PLD > ATT for
PCASL, or (TI-TI1) > ATT for QUIPSS II PASL.
2. There is no outflow of labeled blood water. Because
the tissue water pool is much larger than the blood
water pool, and water exchange between blood and
tissue is rapid, this is generally a valid assumption
(66).
3. The relaxation of the labeled spins are governed by
blood T1. While this assumption is not likely to be
strictly true, the errors introduced by this assump-
tion, which are related to the difference in T1
between blood and tissue, are typically relatively
small.
Under these assumptions, CBF in each voxel can be
calculated for PCASL using (43)
CBF ¼ 6000  l  ðSIcontrol  SIlabelÞ  e
PLD
T1; blood
2  a  T1;blood  SIPD  ð1-e-
t
T1;bloodÞ
½ml=100 g=min
[1]
and for QUIPSS II PASL using (40)
CBF ¼ 6000  l  ðSIcontrol  SIlabelÞ  e
TI
T1; blood
2  a  TI1  SIPD ½ml=100 g=min
[2]
where l is the brain/blood partition coefficient in mL/g,
SIcontrol and SIlabel are the time-averaged signal inten-
sities in the control and label images, respectively,
T1,blood is the longitudinal relaxation time of blood in
seconds, a is the labeling efficiency, SIPD is the signal
intensity of a proton density-weighted image, and t is
the label duration. PLD, TI, and TI1 are as defined above.
The factor of 6000 converts the units from mL/g/s to mL/
(100 g)/min, which is customary in the physiological lit-
erature. Note that for 2D multislice imaging, the value of
TI in these expressions should be adjusted for each slice
to take into account the time delay between slice acquisi-
tions. See Table 3 for a summary of parameters for use in
CBF quantification. Single TI PASL without the QUIPSS
II modification cannot be reliably converted into CBF.
To scale the signal intensities of the subtracted ASL
images to absolute CBF units, the signal intensity of fully
relaxed blood spins is needed. Although several
approaches can yield estimates of this value, we recom-
mend using a separately acquired proton density (PD)
image (represented by SIPD in the above equations) to
obtain this scaling factor on a voxel-by-voxel basis. The
factor l scales the signal intensity of tissue to that of
blood. In principle, l should be an image because tissue
FIG. 7. a: Digital subtraction angiogram (DSA), demonstrating arteriovenous shunting in a patient with a dural AV fistula (black arrow). b:
Intraluminal ASL signal within veins (yellow arrows). Use of vascular crushing may suppress such information, limiting the clinical value
of ASL in this type of case.
Table 3
Values To Be Used in Quantification of ASL Data
Parameter Value
l (blood–brain partition coefficient) 0.9 mL/g (74)
T1,blood at 3.0T 1650 ms (10)
T1,blood at 1.5T 1350 ms (75)
a (labeling efficiency) for PCASL 0.85 (17)
a (labeling efficiency) for PASL 0.98 (19)
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water density differs in different tissue types, but often a
brain average value is used. Strategies to measure l (67)
or to quantify CBF without using l (68,69) have been
proposed but are not in widespread use. Quantification
errors associated with the constant l assumption are
expected to be <10%. Here we recommend the use of a
brain-averaged l, at least until greater optimization and
clinical evaluation of alternative strategies has been per-
formed. The use of a PD image for this scaling serves
two additional important functions. By dividing by this
image, signal variations caused by RF coil inhomogene-
ity, as well as differences in transverse relaxation, are
largely corrected as well. The PD image should have an
identical readout module as the ASL label and control
images, with a long TR to provide proton density weight-
ing. If TR is <5 s, the PD image should be multiplied by
the factor

1=ð1 e-TR=T1;tissueÞ

, where T1,tissue is the
assumed T1 of gray matter, in order to compensate for T1
relaxation. Using a reduced TR and T1 correction may
potentially reduce errors associated with a brain-
averaged l (34,70). No labeling or BS should be applied
for this scan. Care should be taken that the absolute scal-
ing between the signal intensities in this acquisition and
the ASL scans is known. Note that since this PD image
goes in the denominator of the equation, it is important
that its SNR is high and that it is well-coregistered with
the images in the numerator, otherwise its noise contri-
bution can be greatly amplified. A good way of ensuring
this is to apply a motion correction scheme and a
smoothing filter (typically a Gaussian filter of 5–8 mm
diameter) to the PD image.
This model is simplified, but is recommended for its
robustness and simplicity, and because more complete
models require additional information that involves
more scan time, and often only reduces systematic errors
at the cost of SNR. Types of additional information
include ATT, water exchange rates and times between
blood and tissue, tissue T1 values, and tissue segmenta-
tion. Ongoing active research aims to more fully under-
stand the range and effects of these parameters, but the
complexity, uncertainty, and additional noise associated
with correcting for these factors was deemed to be coun-
terproductive as a default protocol at this stage of adop-
tion of clinical ASL.
Estimation of parameters from multi-PLD/TI ASL data
is also an area of active research and depends in detail
on the acquisition parameters and the model used (71).
It is beyond the scope of this article, but we encourage
the user to become familiar with this area of work, as it
may be useful in the interpretation of clinical ASL
images.
ASL in the Clinical Setting
Scan Time
Because the ASL signal is small, ASL relies on averaging
to achieve sufficient SNR. Increasing the number of aver-
ages increases SNR, mitigates the effects of motion arti-
facts, and also provides more opportunities for data
filtering. When using the default parameters described
here, a total scan time of 4 min results in good image
quality in cooperative subjects. For fast imaging in an
acute setting, scan times as low as 2 min may provide
interpretable data, and in these cases we recommend
that spatial resolution should be lowered to compensate
for the SNR loss.
Visualization
One of the key strengths of ASL is that it can produce
absolute measures of CBF. We recommend viewing the
resulting CBF images in either grayscale or color, with a
quantitative scale bar next to the images to indicate CBF
values (Fig. 8). The use of color can improve the ability
to read quantitative CBF values from the scale bar but
can also lead to false apparent thresholds, and the user
should be aware of this potential pitfall.
Detection of White Matter Perfusion
Detection and interpretation of perfusion abnormalities
in the white matter remains challenging due to low SNR
caused by the lower blood flow and prolonged ATT of
white matter compared to grey matter. Furthermore, the
white matter ASL signal can easily be overwhelmed by
gray matter signal due to blurring in either in-plane or
through-plane directions (72). The sensitivity for detec-
tion of white matter perfusion deficits should therefore
be considered to be too small for general clinical use,
though pathologies that exhibit increased perfusion
(such as some tumors), may be detectable.
Quality Assurance
For evaluating the quality of ASL MRI images in clinical
practice, we advise the following checks:
FIG. 8. Example of different methods of displaying CBF informa-
tion in a patient with semantic dementia (note the low CBF in the
left temporal lobe). The images on the left are CBF maps, whereas
the center images show CBF maps using a color map overlaid on
high-resolution T1-weighted images, which are shown separately
on the right. The color scale is in mL/min/100 g. Color CBF maps
may be displayed without anatomical underlay as well.
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1. For PCASL scans, look for areas of low labeling
efficiency. First, identify which arteries should have
been labeled. Typically, this will include internal
and external carotid arteries, and vertebral arteries.
If an angiogram is available, this can be used to ver-
ify the list of labeled arteries. Checking the circle of
Willis anatomy may also be of use in matching vas-
cular territories to labeled arteries. When the label-
ing efficiency is low in an artery, the entire flow
territory of that artery will demonstrate a low calcu-
lated CBF. When a low CBF area is seen that
matches an entire vascular territory, with no appa-
rent compensation from other arteries, a labeling
failure should be considered, though this does not
preclude the possibility of truly low CBF condi-
tions, or abnormally long ATT. Labeling failures can
be caused by tortuous vessels or resonance offsets
in the labeling plane. The former may be addressed
by adjusting the location of the labeling plane, in
which case an additional angiogram would be help-
ful. The latter is commonly caused by dental work,
and may be suggested by signal dropouts around
the teeth in other images from this patient. Methods
to address resonance offset related labeling prob-
lems in PCASL are discussed above.
2. Note the overall gray matter CBF value. Absolute
CBF values obtained in gray matter can vary signifi-
cantly, even among healthy young adults, due to
natural intersubject and intrasubject variations. In
addition, average numbers are sensitive to partial
volume effects and the methods used for isolating
gray matter signal. As a general rule, gray matter
CBF values from 40-100 mL/min/100 mL can be
normal. When the overall gray matter CBF value is
inconsistent with the expected values for the
patient population, consider the possibility that
there is a global reduction in labeling efficiency, or
that the PD scan used for normalization was incor-
rectly acquired or scaled. Clear contrast between
gray and white matter should be present, and if not,
may signify either poor labeling or motion artifacts.
3. Check for motion artifacts. As a subtractive tech-
nique, ASL is motion sensitive, though this sensitiv-
ity is mitigated by BS as discussed above. The
presence of signal outside of the brain, frequently
recognizable as signal from layers of skin or fat is a
clear indication of significant subject motion. When
possible, it may be useful to check individual label/
control difference images before averaging to see
whether artifacts arise from only a minority of these
difference images. If so, these images can be
excluded from the CBF calculation. In addition,
motion correction by means of automated image
registration algorithms can be performed, though
these may not be effective when BS is very efficient,
or when applied to the label/control difference
images, as the individual image SNR in these cases
is low. When BS is not used or is incomplete, image
registration is likely to be more effective, but BS is
nevertheless recommended as a primary means of
reducing physiological noise and motion artifacts.
In the ideal case, prospective motion correction
methods can be used when available to reduce
motion artifacts during acquisition (73), and some
of these methods are compatible with background
suppression.
4. Look for intravascular artifacts. Hyperintense spots
and serpiginous regions often represent intravascu-
lar signal. When observed, it is advisable to verify
that the PLD was appropriate for the patient (see
Table 1), as a low PLD will naturally generate ASL
signals in larger arteries. Intra-arterial signal with a
correct PLD suggests that delivery of labeled blood
to tissue is delayed, through slow flow and/or circu-
itous or collateral routes of circulation. Intravenous
ASL signal suggests that an arteriovenous shunt is
present. Note that CBF calculations over whole
brain or large regions of interest may still be valid
in the presence of intravascular artifact as long as
flow crushing gradients were not used.
5. Check the borderzone (watershed) regions. The bor-
derzone or watershed areas are at the more distal
portions of each vascular territory, and will natu-
rally have a longer ATT than other portions of the
territory. Note that it is possible for low ASL signal
in these regions to represent long ATT rather than
low CBF, and an additional scan with longer PLD
may help to distinguish between these two possibil-
ities. An example of this effect is shown in Fig. 9.
SUMMARY
The guidelines described in this recommendation paper
are intended to help provide clinicians with ASL images
FIG. 9. Borderzone sign. These ASL subtraction images are from
an 85-year-old man with dense left hemiparesis, acquired using
PCASL with a labeling time of 1500 ms and a PLD of 1500 ms.
Only the proximal portions of the arterial tree are present, indicat-
ing that the PLD was not long enough for the labeled spins to
have reached the tissue, and that the ATT was prolonged bilater-
ally in this elderly patient. Although longer PLD should improve
the visualization of parenchymal CBF, it is not uncommon to see
such a finding, known as the borderzone sign, in elderly patients
with extremely delayed arrival times.
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of sufficient quality and SNR to provide diagnostic util-
ity. As a default protocol, we have recommended PCASL
labeling, BS, a segmented 3D RARE-based readout, and
simple but quantitative data processing, and have tabu-
lated recommended parameters. Although these recom-
mendations are intended to promote uniformity and
thereby comparability of ASL data across scanners and
sites, experimentation with parameters and other ASL
methods is encouraged when appropriate. Note that
these recommendations are made as of the date of this
publication, and will likely be superseded in the future,
as more clinical data are collected and analyzed, and as
current and future technical innovations undergo clinical
translation.
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